AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3995960
Drug: Cervical priming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical priming with sulprostone gel
Trial: 28602825
Drug: Bone Level
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone Level Implants (OsseoSpeed TX, Astra tech)
Trial: 28602825
Drug: Tissue Level
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tissue Level Implants (RN SLActive®, Straumann)
Trial: 9506336
Drug: Aspirin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (250 mg/day)
Trial: 10697373
Drug: Tiklid (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiklid (500 mg/day) + Aspirin (250 mg/day)
Trial: 8222740
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (6 g/day)
Trial: 8222740
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil and Fish oil preparation
Trial: 3896432
Drug: Epidural morphine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine, 5 mg in 10 ml 0.9% NaCl
Trial: 30412147
Drug: Add-back hormone
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Add-back hormone replacement therapy with mineral waters (MW) and radon therapy (RT) combined with triptorelin in the main group (MG)
Trial: 30412147
Drug: Triptorelin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin treatment in the control group (CG)
Trial: 15676038
Drug: Giona Easyhaler
RxNorm normalized name: GLYCERIN 0.045 g in 100 mL TOPICAL LIQUID [DIONA CELL REGENERATION BOOSTER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Giona Easyhaler 200 microg/dose
Trial: 15676038
Drug: Pulmicort Turbuhaler
RxNorm normalized name: Pulmicort Turbuhaler
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pulmicort Turbuhaler 200 microg/dose
Trial: 15676038
Drug: Charcoal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Charcoal administration (40 g)
Trial: 27557833
Drug: Rolapitant 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolapitant 180 mg
Trial: 15149513
Drug: Lipid microspheres
RxNorm normalized name: perflutren lipid microspheres
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid microspheres loaded with 0.025% clobetasol propionate (formulation A)
Trial: 15149513
Drug: Lipophilic ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipophilic ointment in a hydrophilic phase 0.025% (formulation B)
Trial: 11052430
Drug: Protective mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective mechanical ventilation (PV; respiratory rate, 16 breaths/min; tidal volume, 6 mL/kg; FIO2, 1.0; PEEP, +5)
Trial: 11052430
Drug: Conventional mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mechanical ventilation (CV; respiratory rate, 8 breaths/min; tidal volume, 12 mL/kg; FIO2, 1.0; PEEP, +5)
Trial: 9771950
Drug: Doxorubicin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (30 mg) plus Verapamil (15 mg)
Trial: 8155011
Drug: Lazabemide 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lazabemide 100 mg/d
Trial: 25526495
Drug: Artificial liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial liver support system (ALSS) plus standard medical therapy (SMT), n = 104
Trial: 25526495
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy (SMT) alone, n = 130
Trial: 16563207
Drug: Self-reported medication
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-reported medication adherence
Trial: 17242421
Drug: Self-reported medication
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-reported medication adherence <80%
Trial: 2085577
Drug: Povidone iodine
RxNorm normalized name: POVIDONE IODINE
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone iodine and nonocclusive dressings changed 2 to 3 times weekly
Trial: 158569
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide gel 2.5%
Trial: 1451291
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide gel 5%
Trial: 158569
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide gel (both strengths)
Trial: 30598384
Drug: Farmed Atlantic
RxNorm normalized name: Atlantic mackerel
DrugBank: Atlantic mackerel (DB15542)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Farmed Atlantic salmon consumption (3 times weekly for 16 weeks)
Trial: 30598384
Drug: Meat consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meat consumption (3 times weekly for 16 weeks)
Trial: 19322115
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol releasing 0.014 mg estradiol (E2)/week
Trial: 15095035
Drug: Milk powder
RxNorm normalized name: Milk powder
DrugBank: Skim milk (DB15546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk powder equivalent to 1300 mg calcium
Trial: 15095035
Drug: Milk powder
RxNorm normalized name: Milk powder
DrugBank: Skim milk (DB15546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk powder equivalent to 650 mg calcium
Trial: 11822993
Drug: Oral cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cocaine 150 mg
Trial: 11822993
Drug: Oral cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cocaine 200 mg
Trial: 10078487
Drug: Control (meningococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (meningococcal vaccine, pneumococcal vaccine, or placebo)
Trial: 2251976
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg BCH 069 (intravenous injection) 3 times weekly for 6 weeks
Trial: 2251976
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg BCH 069 (subcutaneous injection) 3 times weekly for 4 weeks
Trial: 28939607
Drug: Mupirocin-based decolonization
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin-based decolonization therapy
Trial: 19335843
Drug: Newer agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newer agents
Trial: 17163096
Drug: Classic six
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classic six cycles of intravenous CMF
Trial: 24812894
Drug: Comprehensive Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive Western therapy plus blood cooling and detoxification recipe (BCDR)
Trial: 24812894
Drug: Comprehensive Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive Western therapy
Trial: 22894746
Drug: Home self‐testing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home self‐testing for HIV using the OraQuick ADVANCE® HIV‐1/2 Antibody Test on oral fluids
Trial: 12764859
Drug: Auto CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auto CPAP treatment in UPPP group
Trial: 1875221
Drug: ABM infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ABM infusion after CVP
Trial: 30893292
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with reduced-exposure calcineurin inhibitor (CNI, cyclosporine) followed by CNI withdrawal at weeks 7-11 post-transplant
Trial: 16123484
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin (INH group)
Trial: 1550700
Drug: Famotidine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine (40 mg orally)
Trial: 3158146
Drug: Fentanyl 0.3
RxNorm normalized name: fentanyl 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.3 mg
Trial: 29356761
Drug: Comparator (COMP:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator (COMP: intravenous ertapenem followed by oral amoxicillin/clavulanate)
Trial: 21245996
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin plus rebamipide (Rebamipide group)
Trial: 10853861
Drug: External nasal
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External nasal dilator strip (ENDS) with nasal decongestant
Trial: 3128527
Drug: Cold air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold air inhalation (2 degrees C)
Trial: 18612879
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg) for three days
Trial: 15778874
Drug: Dronabinol (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (10, 20 mg)
Trial: 15778874
Drug: Dronabinol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (30 mg)
Trial: 15486365
Drug: Intensive oral
RxNorm normalized name: Uricalm Intensive Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive oral care (teeth and gingiva cleaned after every meal for 1 month)
Trial: 15486365
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (performed their own oral care for 1 month)
Trial: 9758291
Drug: Trovafloxacin 200
RxNorm normalized name: trovafloxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 200 mg once daily
Trial: 9758291
Drug: Amoxicillin 1
RxNorm normalized name: amoxicillin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 1 g three times daily
Trial: 356718
Drug: Theophylline and
RxNorm normalized name: theophylline and adrenergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline and hydroxyzine (basic combination)
Trial: 21594560
Drug: D-cycloserine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine (100 mg)
Trial: 31410659
Drug: Febuxostat therapy
RxNorm normalized name: Febuxostat
DrugBank: Febuxostat (DB04854)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Febuxostat therapy
Trial: 31410659
Drug: No application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No application of febuxostat therapy
Trial: 10622051
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with doxycycline 100 mg twice daily for 10 days
Trial: 2913892
Drug: Once-daily theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily theophylline preparation
Trial: 132901
Drug: Topical tetracycline
RxNorm normalized name: TETRACYCLINE HYDROCHLORIDE 30 mg in 1 mL TOPICAL SPRAY [Tetracyte Topical Tetracycline Hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline hydrochloride and orally administered lactose capsules
Trial: 132901
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered tetracycline hydrochloride and topically applied placebo liquid
Trial: 132901
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied placebo liquid and orally administered tetracycline hydrochloride
Trial: 27908689
Drug: PCSK9 genetic
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCSK9 genetic variants (rs11583680, rs11591147, rs2479409, rs11206510) scaled to 1 mmol/L lower LDL cholesterol
Trial: 25181297
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for regular past tense, one-hour play-based sessions, once weekly for eight weeks
Trial: 25181297
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for regular past tense
Trial: 17026815
Drug: Gemcitabine 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1250 mg/m² on days 1 and 8 plus carboplatin AUC 5 on day 1
Trial: 11126695
Drug: Randomised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomised treatment allocation
Trial: 8989012
Drug: Fentanyl 1.5
RxNorm normalized name: fentanyl 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1.5 micrograms/kg intravenous (i.v.) administration
Trial: 8452180
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg daily for 7 days
Trial: 8452180
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg daily for 14 days
Trial: 8452180
Drug: Chloramphenicol 50
RxNorm normalized name: chloramphenicol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol 50 mg/kg per day for 14 days
Trial: 3088648
Drug: Naloxone (0.0625,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.0625, 0.25, 1.0, or 4.0 mg/kg)
Trial: 24619608
Drug: Brace treatment
RxNorm normalized name: Brace Relief
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brace treatment (Br group)
Trial: 16652130
Drug: bioactive supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bioactive supplement (n=57)
Trial: 11834192
Drug: Olanzapine (OLZ)
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine (OLZ) 2.5 or 5.0 mg daily
Trial: 314777
Drug: Low-dosage ampicillin
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dosage ampicillin (150 mg/kg per day)
Trial: 28390417
Drug: Standard cognitive‐behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive‐behavioral smoking cessation treatment
Trial: 28390417
Drug: Standard cognitive‐behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive‐behavioral smoking cessation treatment plus behavioral activation
Trial: 16132779
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) therapy at a dose of 2000 U subcutaneously thrice weekly
Trial: 2006566
Drug: Lovastatin 40
RxNorm normalized name: lovastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 40 mg daily for 30 days
Trial: 6754505
Drug: Gentamicin otic
RxNorm normalized name: gentamicin Otic Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin otic solution (0.3%)
Trial: 6754505
Drug: Colistin-neomycin-hydrocortisone otic
RxNorm normalized name: colistin / hydrocortisone / neomycin / thonzonium Otic Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colistin-neomycin-hydrocortisone otic suspension (colistin 0.3%, neomycin 0.33%, hydrocortisone 1.0%)
Trial: 28728599
Drug: CinnoRA® (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CinnoRA® (40 mg subcutaneous injections every other week)
Trial: 28728599
Drug: Humira® (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Humira® (40 mg subcutaneous injections every other week)
Trial: 12176948
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg monotherapy for 2 years
Trial: 7857504
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of hypericum per day combined with bright light therapy (3000 lux)
Trial: 7857504
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of hypericum per day combined with dim light therapy (< 300 lux)
Trial: 8899078
Drug: Sucrose polyester
RxNorm normalized name: polyester-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose polyester (50 g as a single drink)
Trial: 6679229
Drug: Verapamil (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (IV administration, bolus of 0.075 mg/kg up to 5 mg)
Trial: 6679229
Drug: Verapamil (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (IV administration)
Trial: 19720927
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg alone
Trial: 19720927
Drug: Bevacizumab plus
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab plus irinotecan 340 mg/m2 or 125 mg/m2
Trial: 9000658
Drug: MMF 2
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 2 g and MMF 3 g
Trial: 24152889
Drug: Ferrous bisglycinate
RxNorm normalized name: FERROUS BISGLYCINATE
DrugBank: Ferrous bisglycinate (DB11210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous bisglycinate 25 mg iron/day
Trial: 24152889
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate 50 mg iron/day
Trial: 15998425
Drug: Non-interferon-based therapy
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-interferon-based therapy (N-IFN-BT) - ribavirin (600-800 mg) + amantadine (200 mg) + ursodeoxycholic acid (UDCA) (500 mg) for 24 weeks
Trial: 15998425
Drug: Non-interferon-based therapy
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-interferon-based therapy (N-IFN-BT)
Trial: 15998425
Drug: Silymarin therapy
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin therapy - 450 mg/day for 24 weeks
Trial: 8886216
Drug: Naprelan 1000
RxNorm normalized name: Naprelan
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naprelan 1000 mg
Trial: 2268862
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg
Trial: 19937046
Drug: Codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine 30 mg
Trial: 22775078
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept 4 mg
Trial: 22775078
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept 0.15 mg
Trial: 20151792
Drug: Estradiol (E2)
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol (E2) 1 mg/day + norethisterone acetate (NETA) 0.5 mg/day for 2 months, followed by placebo for 4 months
Trial: 12697871
Drug: Three 72-hour
RxNorm normalized name: THREE-LOBE SAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three 72-hour infusions of carmustine (BiCNU) and cisplatin followed by radiation therapy
Trial: 12697871
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with standard adjuvant BiCNU
Trial: 7902369
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of naltrexone
Trial: 2994500
Drug: Schedule A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule A (once daily by rapid infusion)
Trial: 2994500
Drug: Schedule B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule B (continuous 24 hr infusion)
Trial: 2994500
Drug: Schedule C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule C (divided doses every eight hours by rapid infusion)
Trial: 23364033
Drug: Passive upper
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Passive upper arm exercise for 30 minutes per session, twice a day for 2 weeks
Trial: 15940046
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (LDD) infusion over the second 3-hr period
Trial: 15940046
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (LDD) infusion over both the first and third 3-hr periods
Trial: 10412886
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of paracetamol orally
Trial: 7002479
Drug: Glucosamine sulphate
RxNorm normalized name: Glucosamine Sulfate 750 MG Oral Capsule [GLUCOSAMINE SULPHATE]
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulphate (250 mg, 3 times daily for 6 to 8 weeks)
Trial: 7002479
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 capsules, 3 times daily for 6 to 8 weeks)